AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06090851 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: herbal nitrate Pralines without nitrate
Description: consumption of herbal pralines without nitrate
Study NCT05530720 — intervention group
Intervention type: OTHER
Intervention: Cross-sectional survey
Description: No intervention.
Study NCT05198336 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Inactivated COVID-19 Vaccine
Description: 600SU inactivated virus in 0.5 mL of aluminium hydroxide solution per injection
Study NCT05301868 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multidomain intervention
Description: For 24 weeks, participants will receive cognitive training twice a week, exercise 3 times a week, nutrition education 12 times, and education about vascular risk factor management every 2 weeks using the tablet PC application.
Study NCT05247814 — intervention group
Intervention type: GENETIC
Intervention: Pharmacogenomic testing of a panel of important pharmacogenes to detect genetic variants and evaluate the association between genetically predicted and measured drug metabolism
Description: All planned interventions are explorative analyses of biological and genetic risk profiles that can contribute to patients' individual risk for adverse drug reactions, i.e. due to variability in drug metabolism
Study NCT05247814 — intervention group
Intervention type: OTHER
Intervention: Adverse Drug Reaction detection
Description: During appointments in the university outpatient clinic, patients will undergo a comprehensive adverse drug reaction (ADR) assessment based on an ADR diary they were handed at enrolment
Study NCT05247814 — intervention group
Intervention type: OTHER
Intervention: Falls Efficacy Scale International (FES-I)
Description: The FES-I wil be obtained to estimate fear of falling
Study NCT05672511 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simulation Teaching Method
Description: Randomly determined experimental group students will perform eight vaginal examination scenarios different in terms of cervical effacement, cervical dilatation, presence of amniotic membrane, presenting fetus part, position of the fetus and fetal descent on the fetal monitoring and labor progress model set in the laboratory. The control group will not receive any simulation training. Both groups will be given a knowledge test after teaching with simulation. Students in both groups will fill out a form evaluating their skills in performing the steps of vaginal examination before each vaginal examination is performed on women in the clinic.
Study NCT05780255 — intervention group
Intervention type: DEVICE
Intervention: VV-ECMO
Description: veno-venous extracorporeal membrane oxygenation
Study NCT05403320 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous cuff pressure regulation
Description: Within 24 hours, AnapnoGuard tube will be connected to AnapnoGuard 100 control device. It includes an automatic high-sensitive subglottic capnograph which measures every few minutes the carbon dioxide level in the subglottic space. If the level of carbon dioxide is above the threshold (established by animal studies) the system will increase the cuff pressure by a formula, if the level is below the threshold, the system will decrease the cuff pressure by 1 mmHg. Variations of cuff pressure are allowed only between pressure limits set by the user (minimum and maximum)
Study NCT05403320 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intermittent cuff pressure regulation
Description: ET cuff pressure will be manually measured three times per day using a portable manometer, and kept constant within 20-30 cmH2O
Study NCT05403320 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Automatic subglottic secretion drainage
Description: Within 24 hours, AnapnoGuard tube will be connected to AnapnoGuard 100 device control which provides continuous subglottic secretion drainage (two different suction lines) and venting/rinsing (a third dedicated line)
Study NCT05403320 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Manual subglottic secretion drainage
Description: Subglottic secretions will be manually drained with a 10 mL syringe, using the only dedicated lumen
Study NCT05403320 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Tracheobronchial colonization assessment
Description: Tracheal aspirate will be performed after intubation and after 72 hours for microbiological colture
Study NCT05403320 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Tracheobronchial colonization assessment
Description: Tracheal aspirate will be performed after intubation and after 72 hours for microbiological colture
Study NCT05403320 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Microaspiration assessment
Description: Tracheal aspirates will be performed 72 hours after intubation, and collected in a predefined study center to measure pepsin and salivary amylase
Study NCT05403320 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Microaspiration assessment
Description: Tracheal aspirates will be performed 72 hours after intubation, and collected in a predefined study center to measure pepsin and salivary amylase
Study NCT05403320 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: VAP assessment
Description: Patients will be follow to detect clinical, radiological or microbiological signs of VAP. If suspected, a tracheal aspirate or a bronchoalveolar lavage is performed to confirm the diagnosis
Study NCT05403320 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: VAP assessment
Description: Patients will be follow to detect clinical, radiological or microbiological signs of VAP. If suspected, a tracheal aspirate or a bronchoalveolar lavage is performed to confirm the diagnosis
Study NCT05560373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Huperzine A injection, operational treatment, the best basic treatment
Description: intramuscular
Study NCT05560373 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: operational treatment, the best basic treatment
Description: other
Study NCT05560373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Huperzine A injection, interventional treatment, the best basic treatment
Description: intramuscular
Study NCT05560373 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Interventional treatment, the best basic treatment
Description: other
Study NCT05184673 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral and environmental
Description: These are all active comparator yoga sequences
Study NCT05381142 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elinzanetant (BAY3427080)
Description: Elinzanetant will be administered as a single dose on Study Day 1 and a multiple dose once daily for another 6 consecutive days on Study Day 8 to Study Day 13.
Study NCT05381142 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo will be administered the same as Elinzanetant (BAY3427080)
Study NCT05664542 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ESPB (regional Block)
Description: ESPB is regional block in which we will use 0.2 % ropivacaine and dexmedetomidine
Study NCT05664542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ropivacaine and dexmedetomidine
Description: 0.2 % ropivacaine and dexmedetomidine
Study NCT05636592 — intervention group
Intervention type: DRUG
Intervention: immunotherapy
Description: statin combined with immunotherapy
Study NCT05355272 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone
Description: recombinant human growth hormone (rhGH)
Study NCT05003622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Encorafenib
Description: oral capsule
Study NCT04086082 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Markerless Image Guidance
Description: Single arm trial using implanted markers to determine the feasibility of Markerless Image Guidance using Intrafraction Kilovoltage X-ray Imaging
Study NCT06025669 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nap restriction
Description: There are 2 interventions in the single-arm, that is, the nap rested condition and the nap restriction condition. The sequence of nap intervention followed randomization.
Study NCT04593862 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training
Description: The intervention will be performed on a treadmill and will include a warm-up and cool-down at 50-60% and 40% of the VO2peak respectively, for up to five minutes. The HIIT protocol will be 4x4, which consists of four bouts of four minutes at a workload corresponding to vigorous intensity (75-95% of the baseline and 6-week VO2peak) alternating with three minutes of recovery intervals at 40% of the VO2peak. The exercise session will last 35 minutes and include 16 minutes of high intensity exercise.
Study NCT06212726 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: InjureFree
Description: The InjureFree software is a commercialized injury incident management platform for organizations working in sports and athlete care and is focused on providing administrators and caregivers' technology to enhance coordination of care. InjureFree will be utilized to track concussion management and communication following SRRC at Buchholz and Gainesville High Schools. This will not modify the current standard of practice for healthcare delivery, it will only modify the communication between members of the concussion management team
Study NCT06653387 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CGuard Prime 80cm stent system
Description: This study is single arm looking at the technical success of the CGuard Prime 80cm stent system when used in conjunction with the FDA-cleared ENROUTE NPS during a TCAR procedure.
Study NCT06651840 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: bipolar diathermy Standard technique.
Description: The bipolar technique for group A:~A bipolar with straight blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power.~The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively.
Study NCT04777435 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Therapeutic orientation test for TMA
Description: Therapeutic orientation test for TMA performed on blood sample at inclusion, first visit at 1 month and last visit at 6 months.
Study NCT06547658 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mouth closure
Description: Closing the mouth during sleep by applying pressure to the mentum until the teeth were in occlusion, without altering the head position.
Study NCT04967079 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib
Description: Trametinib 2 mg given orally, once daily
Study NCT04967079 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib
Description: Anlotinib given orally, every two weeks followed by a one-week discontinuation cycle
Study NCT04943081 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous nephrolithotomy
Description: Percutaneous nephrolithotomy (PCNL) is a technique used to remove complex renal stones, or stones resistant to shockwave lithotripsy. A tube is placed through the incision in the kidney, under X-ray guidance, and renal stones are extracted by using nephroscope
Study NCT04869345 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LARKSPUR
Description: This intervention used in our prior research consists of skills training exercises designed to increase the frequency of positive affect. The 6 week intervention (5 weeks of content plus one week of home practice) consists of five components: (1) Positive events and gratitude; (2) mindfulness; (3) reappraisal; (4) strength and goals; and(5) acts of kindness. Participants will have up to 8 weeks to complete this intervention.
Study NCT05506176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIM0417
Description: dose of 750 mg SIM0417 with 100 mg ritonavir.
Study NCT05506176 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo (tablet)
Study NCT04972240 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: customization of abutment
Description: we will customize abutment for every patient not ready made
Study NCT06214247 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wedge NC Scoring Balloon Dilatation Catheter
Description: During PCI, percutaneous transluminal coronary angioplasty is performed on the target lesion using the Wedge NC Scoring Balloon Dilatation Catheter in the test group, subsequently completing the remaining procedure.
Study NCT06214247 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Scoreflex Scoring Balloon Dilatation Catheter
Description: During PCI, percutaneous transluminal coronary angioplasty is performed on the target lesion using a similar product on the market in the control group, subsequently completing the remaining procedure.
Study NCT05396079 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: tahini and bread
Description: Fifthy grams of tahini with 2 slices of white bread
Study NCT05396079 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: margarine, cheese and bread
Description: 46 g of margarine and 38 g of cheese with 2 slices of white bread
Study NCT06365866 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BRAXX Esophageal Brachytherapy Applicator.
Description: The device is intended for use with a commercially available after loader during brachytherapy. The purpose of the device is to deliver a radioactive source to the esophagus. This device is sterile, disposable, and single-use.
Study NCT06365866 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Add-on of intraluminal brachytherapy
Description: Brachytherapy protocol starts within 12 weeks after EBRT. High-dose-rate (HDR) 5-Gy per fraction is delivered to GTV of esophageal tumor(s), second fraction (if applicable) to be done within 2 weeks after the first fraction, for a total of 5-10Gy in 1-2 fractions will be delivered.
Study NCT04977102 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intraocular caliper-assisted capsulotomy
Description: Intraocular caliper is a modified intraocular caliper with standard calibration on the rinse needle.
Study NCT04977102 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Verion navigation system-assisted capsulotomy
Description: Verion Image Guided System (Alcon Laboratories, Inc.) is a digital image guidance system consisting of a diagnostic reference unit and a surgery pilot for intraoperative surgical assistance. The device can be used to align toric intraocular lens during surgery as well as support manual creation of a capsulorhexis with a predefined target diameter.
Study NCT05767554 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief modified behavioral activation
Description: The clinician will deliver psychoeducation about the nature of depression and the rationale behind the behavioral activation model (i.e. increasing level of activation can begin a positive feedback cycle of reward and improvements in mood state). Participants will be encouraged to add new, enjoyable activities to their daily schedules. Clinicians will emphasize the importance of novelty and increased engagement with the surrounding environment in the psychoeducational portion and in activity scheduling.
Study NCT06651840 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: coblation technique.
Description: The coblation technique for group B:~An coblator with tonsillar blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power.~The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively.
Study NCT05162027 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Erenumab-Aooe 70 MG in 1 mL Prefilled Syringe
Description: Administered once every 4 weeks/28 days at visit 1, visit 2 and visit 3 for a total of 3 cycles.
Study NCT05162027 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered once every 4 weeks/28 days at visit 1, visit 2 and visit 3 for a total of 3 cycles.
Study NCT04672564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carrimycin
Description: Carrimycin (400 mg) will be given once-daily for 14 days (2 x 200 mg tablets) after a meal, if a patient experiences an eating problem, carrimycin will be taken without food.
Study NCT04672564 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be given once-daily for 14 days (2 tablets) after a meal, if a patient experiences an eating problem, placebo will be taken without food.
Study NCT05251740 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Altimate Medical EasyStand Bantam
Description: The child will stand in the device for 60 min per day, 5 days per week for 2 months.
Study NCT04750759 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Niclosamide + Camostat
Description: Niclosamide will be applied in combination with camostat.
Study NCT04750759 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to interventional drug
Study NCT06401122 — intervention group
Intervention type: PROCEDURE
Intervention: haemodialysis
Description: process of filtering the blood of a person whose kidneys are not working normally from uremic toxins
Study NCT04860375 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multidisciplinary patient care
Description: A holistic, multidisciplinary, patient-centered care.
Study NCT04860375 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: Standard care in Sweden
Study NCT05260853 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Weaning Board
Description: structured care concept
Study NCT06236295 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR6508
Description: SHR6508 will be administered to all the eligible subjects
Study NCT05242055 — intervention group
Intervention type: OTHER
Intervention: Integrated diagnosis and treatment for CKD
Description: This is an observational study. Investor will not intervene the clinical practice of doctors. In the real world, there would be many factors affect the proceeding of the guidelines contents. There will be integrated diagnosis and treatment during follow-up.
Study NCT05687968 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 3D/AR MetaFood  nutrition education, and receive instant feedback from the nutritionists or AI after recording their dietary food image.
Description: The participants record diet images by using Taiwan FoodAPP and receive instant feedback from the nutritionists or AI after recording their dietary food image. The dietitian will use 3D/AR MetaFood food nutrition education platform to do nutrition education for patients.
Study NCT05687968 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: conventional nutrition education by dietitian
Description: The participants receive conventional health and nutrition education from state registered dietitian.
Study NCT06323564 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Neuropsychological tests in PD
Description: Colored Progressive Matrices (BDM), Stroop Test (Caffarra et al., 2000), Stroop Test (Caffarra et al., 2000), Attentional Matrices (part I - Della Sala et al., 1992), Attentional Matrices (part The - Della Sala et al., 1992), Trail Making Test (Giovagnoli et al., 1996 - part A), Trail Making Test (Giovagnoli et al., 1996 - part B), Trail Making Test (Giovagnoli et al., 1996 - B-A), MMSE (Grigoletto et al., 1999), Clock Drawing - PD (Caffarra et al., 2011), Digit Span Forward (Orsini et al., 1987), Digit Span Backward (Monaco et al. , 2012), 15 Rey Words - Immediate Recall (BDM), 15 Rey Words - Deferred Recall (BDM), Phonemic Fluency (Costa et al., 2014), Semantic Fluency (Costa et al., 2014), Frontal Assessment Battery ( FAB - Apollonio et al.,2005).
Study NCT06323564 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Self-report questionnaires in PD
Description: STAI Y2 (trait anxiety), TEIque (153 items), STAI Y1 (state anxiety), ERQ (10 items), EISR (33 items), BDI (21 items), WLEIS (16 ITEMS), CFI (20 ITEMS ), CCFQ (18 ITEM).
Study NCT06323564 — intervention group
Intervention type: DEVICE
Intervention: International Affective Picture System (IAPS)
Description: Subsequently, at both T0 and T1, standardized emotional images from the International Affective Picture System (IAPS) will be administered. The images will be chosen based on the arousal-valence parameters, eliminating those with stimuli that are too salient with respect to the disorders examined. The order of administration will be organized and randomized between subjects as follows: 24 blocks of 2 minutes and for each block there will be 12 images of 10 seconds each. For the entire duration of the test, peripheral physiological parameters such as ECG, BVP, GSR, EOG, RSP and facial EMG (corrugator and zygomaticus) will also be detected, as objective measures of emotional arousal (T0-T1).
Study NCT06323564 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Neuropsychological tests in AN
Description: Verbal Fluencies, Tower of London, TMT-A \& B